ZYAMTIN
associated with 6 other trademarks
Biological preparations for medical use in medical and clinical gene therapy and cell therapy; clinical medical reagents for use in gene therapy, gene...

Words that describe this trademark:

clinical gene therapy  medical medical  cell therapy  medical clinical  clinical medical  therapy cell  biological preparations  gene therapy  therapy  preparations 

Serial Number:

77179359

Mark:

ZYAMTIN

Status:

Cancelled-Section 8

Status Date:

05-12-2017

Filing Date:

Registration Number:

3855311

Registration Date:

10-05-2010

Goods and Services:

Biological preparations for medical use in medical and clinical gene therapy and cell therapy; clinical medical reagents for use in gene therapy, gene diagnosis, and gene testing; pharmaceutical preparations, namely, vaccines for use in gene therapy; gene therapy and prophylaxis products, namely, gene-based biological preparations and medical reagents for use in gene regulation and gene modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, cancer, inflammatory and auto-immune diseases, vascular disorders, and single gene disorders

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

03-02-2010

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

MORRISON & FOERSTER LLP

Correspondent Name:

Recent Trademark filings by this company